Kelly is a computational biologist with a passion for developing tools in pursuit of understanding human disease. Her background is in using mathematical modeling, machine learning, and other computational methods to better understand protein and RNA evolution, structure, and interactions. Kelly has experience building collaborations across multiple labs and biological applications, including structural analysis for difficult to characterize protein and RNA targets and modeling immune escape for SARS-CoV-2 variants. When the opportunity to join the Kernal Bio team arose, she was very excited to gain experience in sequence engineering for oncotherapeutics. She earned her Ph.D. in Computational and Systems Biology from MIT in Jeremy England's biophysics group. She then went on to do a joint postdoc with Debora Marks and Chris Sander at Harvard Medical School, where she was later promoted to Associate Research Director in the Marks lab. When she's not wrangling a piece of software to do her bidding, she can likely be found either playing with her tiny Yorkie, Frodo Baggins Brock-Lazovich, or practicing lightsaber choreography.